An update on phosphate binders for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis: a review of safety profiles-Reference-Cited by-同舟云学术

An update on phosphate binders for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis: a review of safety profiles

Published:2022-02-21 Issue:7 Volume:21 Page:947-955
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Ogata Hiroaki¹^ORCID,Takeshima Akiko¹,Ito Hidetoshi¹

Affiliation:

1. Division of Nephrology, Department of Internal Medicine, Showa University, Northern Yokohama Hospital, Chigasaki-chuo 35-1, 2248503, Tsuzuki, JAPAN

Funder

JSPS KAKENHI

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2022.2044472

Reference85 articles.

1. Oral Phosphate Binders in Patients with Kidney Failure

2. Prevention and treatment of hyperphosphatemia in chronic kidney disease

3. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD)

4. Functional impairment attenuates the association between high serum phosphate and mortality in dialysis patients: a nationwide cohort study

5. Hyperphosphataemia: which phosphate binder?

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hyperphosphatemia in Chronic Kidney Disease: The Search for New Treatment Paradigms and the Role of Tenapanor;International Journal of Nephrology and Renovascular Disease;2024-05

2. Ferric citrate for the treatment of hyperphosphatemia and iron deficiency anaemia in patients with NDD-CKD: a systematic review and meta-analysis;Frontiers in Pharmacology;2024-03-07

3. Ferric citrate’s efficacy for hyperphosphatemia and anemia in NDD-CKD: a meta-analysis;Third International Conference on Biological Engineering and Medical Science (ICBioMed2023);2024-01-08

4. The deposition of lanthanum carbonate may activate macrophages to induce gastrointestinal mucosal injury in patients with chronic kidney disease: an in vitro caco-2/THP-1 macrophage coculture model study;JBIC Journal of Biological Inorganic Chemistry;2023-12-26

5. Patterns of gastrointestinal injury in patients with chronic kidney disease: Comparison of cases with and without sevelamer crystals;Histopathology;2023-12-04